In the specific case of MM, it has been described that the Raf/Mek/Erk pathway undoubtedly participates in its pathophysiology, contributing to its growth, while the JNK and p38 pathways seem to have an indirect role in growth or the mechanisms of resistance to current therapies. Here, MAPK1 is linked to Miyoshi myopathy.